title: A case of L-dopa-responsive parkinsonian syndrome after low-dose oral methotrexate intake.
authors.affiliation: Department of Neurology, Regional University Hospital, Patras, Greece. spapapetropoulos@med.miami.edu
authors.forename: Spiridon
authors.initials: S
authors.lastname: Papapetropoulos
authors.forename: Andreas A
authors.initials: AA
authors.lastname: Argyriou
authors.forename: Stamatis-Nick C
authors.initials: SN
authors.lastname: Liossis
authors.forename: Dimitrios
authors.initials: D
authors.lastname: Daousis
authors.forename: Georgios
authors.initials: G
authors.lastname: Katsoulas
authors.forename: Dimitrios
authors.initials: D
authors.lastname: Apostolopoulos
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Chroni
mesh_terms: D000368:Aged; D000978:Antiparkinson Agents / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use*; D008727:Methotrexate / Q000009:adverse effects*; D010302:Parkinson Disease, Secondary / Q000139:chemically induced* / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D000978:Antiparkinson Agents; D018501:Antirheumatic Agents; D007980:Levodopa; D008727:Methotrexate